|
ReBuilder Medical Technologies, Inc.'s Recent Stock Price Volatility Explained
 | |
ReBuilder Medical Technologies logo. (PRNewsFoto/ReBuilder Medical Technologies, Inc.)
CHARLES TOWN, WV UNITED STATES
| | |
Unique Buying Opportunity Presented
CHARLES TOWN, W.Va., Nov. 23 /PRNewswire-FirstCall/ -- ReBuilder
Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for
diabetic peripheral neuropathy and Molluscum Contagiosum, today announced
it has successfully concluded analysis of the recent volatility of their
stock price and presented it to the Board of Directors.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
It appears that several institutional and corporate investors possibly
got nervous over the sub-prime housing crisis and liquidated large portions
of their portfolios. "Unfortunately, our equity was included in their
programmed liquidation process. As a result, many individual investors
followed suit, increasing the supply of stock available to purchase and
driving down the price per share," according to David Phillips, Ph.D. CEO.
Meanwhile the company continued its steady growth as evidenced by the
quarterly reports published on pinksheets.com. There was no bad news
whatsoever relative to the actual operations of the company. "We are in
better financial shape, in better marketing shape, in better R&D shape, and
in better PR shape than ever before in our company's history," says Dr.
Phillips.
"We have successfully renegotiated certain aspects of our original
merger terms to reduce the possibility of any remaining large corporate
holders of our equities from taking profits and dumping large blocks of our
stock on the market. In addition, many of these original holders of large
blocks of our equities have now liquidated the majority of their shares to
individual investors. We expect that these new individuals may have the
best long-term interests of our company in mind. This could have the
desired effect of stabilizing the stock price and thus reflect the real
value of our equities," states Dr. Phillips. He concluded his statement by
saying, "Because I, personally, am an insider, I cannot buy my own
company's stock. However, if I could, I would sell my dog if I had to, to
buy some."
Beginning on Monday, November 26, 2007, RBRM will be releasing a series
of twelve news releases that will describe several new initiatives that are
very exciting and will help investors have a better understanding of the
company's current success and plans to expand that success in the near
future.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which
are intended to be covered by the safe harbors created thereby. Investors
are cautioned that all forward-looking statements involve risks and
uncertainty, including without limitation, the ability of the Company to
successfully implement its turnaround strategy, changes in costs of raw
materials, labor, and employee benefits, as well as general market
conditions, competition and pricing. Although the Company believes that the
assumptions underlying the forward-looking statements contained herein are
reasonable, any of the assumptions could be inaccurate, and therefore,
there can be no assurance that the forward-looking statements included in
this letter will prove to be accurate. In light of the significant
uncertainties inherent in the forward-looking statements included herein,
the inclusion of such information should not be regarded as representation
by the Company or any other person that the objectives and plans of the
Company will be achieved. In assessing forward-looking statements included
herein, readers are urged to carefully read those statements. When used in
the Annual Report on Form 10-K, the words "estimate," "anticipate,"
"expect," "believe," and similar expressions are intended to be
forward-looking statements.
|
